v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Underwritten Offering
Common Stock
Common Stock
Underwritten Offering
Additional Paid-in Capital
Additional Paid-in Capital
Underwritten Offering
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance, shares at Dec. 31, 2024     283,218,344          
Beginning balance at Dec. 31, 2024 $ 423,499   $ 28   $ 1,190,729   $ 405 $ (767,663)
Exercise of stock options, shares     47,372          
Exercise of stock options 33       33      
Stock-based compensation expense 6,713       6,713      
Net loss (30,966)             (30,966)
Unrealized gain (loss) on marketable securities, net 223           223  
Ending balance, shares at Mar. 31, 2025     283,265,716          
Ending balance at Mar. 31, 2025 399,502   $ 28   1,197,475   628 (798,629)
Beginning balance, shares at Dec. 31, 2024     283,218,344          
Beginning balance at Dec. 31, 2024 423,499   $ 28   1,190,729   405 (767,663)
Net loss (64,842)              
Ending balance, shares at Jun. 30, 2025     283,650,139          
Ending balance at Jun. 30, 2025 372,258   $ 28   1,204,320   415 (832,505)
Beginning balance, shares at Mar. 31, 2025     283,265,716          
Beginning balance at Mar. 31, 2025 399,502   $ 28   1,197,475   628 (798,629)
Exercise of stock options, shares     63,332          
Exercise of stock options 43       43      
Issuance of common stock under the Employee Stock Purchase Plan, shares     321,091          
Issuance of common stock under the Employee Stock Purchase Plan 404       404      
Stock-based compensation expense 6,398       6,398      
Net loss (33,876)             (33,876)
Unrealized gain (loss) on marketable securities, net (213)           (213)  
Ending balance, shares at Jun. 30, 2025     283,650,139          
Ending balance at Jun. 30, 2025 $ 372,258   $ 28   1,204,320   415 (832,505)
Beginning balance, shares at Dec. 31, 2025 284,159,076   284,159,076          
Beginning balance at Dec. 31, 2025 $ 325,171   $ 28   1,216,724   628 (892,209)
Issuance of common stock, share       25,875,000        
Issuance of common stock   $ 242,706   $ 3   $ 242,703    
Exercise of stock options, shares     772,812          
Exercise of stock options 1,958       1,958      
Stock-based compensation expense 8,460       8,460      
Net loss (183,440)             (183,440)
Unrealized gain (loss) on marketable securities, net (1,327)           (1,327)  
Ending balance, shares at Mar. 31, 2026     310,806,888          
Ending balance at Mar. 31, 2026 $ 393,528   $ 31   1,469,845   (699) (1,075,649)
Beginning balance, shares at Dec. 31, 2025 284,159,076   284,159,076          
Beginning balance at Dec. 31, 2025 $ 325,171   $ 28   1,216,724   628 (892,209)
Net loss $ (227,519)              
Ending balance, shares at Jun. 30, 2026 312,556,206   312,556,206          
Ending balance at Jun. 30, 2026 $ 361,869   $ 31   1,482,815   (1,249) (1,119,728)
Beginning balance, shares at Mar. 31, 2026     310,806,888          
Beginning balance at Mar. 31, 2026 393,528   $ 31   1,469,845   (699) (1,075,649)
Exercise of stock options, shares     1,143,041          
Exercise of stock options 2,595       2,595      
Issuance of common stock under the Employee Stock Purchase Plan, shares     606,277          
Issuance of common stock under the Employee Stock Purchase Plan 769       769      
Stock-based compensation expense 9,606       9,606      
Net loss (44,079)             (44,079)
Unrealized gain (loss) on marketable securities, net $ (550)           (550)  
Ending balance, shares at Jun. 30, 2026 312,556,206   312,556,206          
Ending balance at Jun. 30, 2026 $ 361,869   $ 31   $ 1,482,815   $ (1,249) $ (1,119,728)